Protalix BioTherapeutics (PLX) Other Non-Current Assets (2010 - 2017)

Protalix BioTherapeutics' Other Non-Current Assets history runs 6 years deep, the most recent figure standing at $211000.0 for Q3 2017.

• On a quarterly basis, Other Non-Current Assets fell 35.47% year-over-year to $211000.0 in Q3 2017; TTM through Sep 2017 was $211000.0, a 35.47% decrease from a year earlier, with the FY2016 full-year figure at $327000.0, down 84.23% from the prior year.
• Other Non-Current Assets declined to $211000.0 in Q3 2017 per PLX's latest filing, from $213000.0 in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $5.1 million in Q4 2014 and bottomed at $205000.0 in Q1 2017.
• The 4-year median for Other Non-Current Assets is $327000.0 (2016), against an average of $1.1 million.
• Across the five-year window, Other Non-Current Assets slumped 84.23% in 2016 and slumped 34.26% in 2017, its largest moves.
• Year by year, Other Non-Current Assets stood at $5.1 million in 2014, then tumbled by 59.35% to $2.1 million in 2015, then slumped by 84.23% to $327000.0 in 2016, then tumbled by 35.47% to $211000.0 in 2017.
• Per Business Quant, the three latest PLX Other Non-Current Assets figures stand at $211000.0 (Q3 2017), $213000.0 (Q2 2017), and $205000.0 (Q1 2017).